Insider trades

Daniel Billen, Director of Aurinia Pharmaceuticals AUPH, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/05/21.

Daniel Billen

Director
First filing
23/05/23
Trades
6 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
24/05/21

Trading activity

Transactions

Trade type
Open-market sale24/05/2124/05/225,252 sh$5.74$30,146.48−15.7%
Open-market sale23/05/2323/05/234,650 sh$11.26$52,359−12.2%